BIOQuébec and Canada's Research-Based Pharmaceutical Companies collaborate to drive development of industry in Quebec

OTTAWA, June 14, 2012 /CNW/ - BIOQuébec and Canada's Research-Based Pharmaceutical Companies (Rx&D) today signed a partnership agreement aimed at reinforcing the linkages and alignment between the biotechnology and pharmaceutical associations in support of life science research in Quebec.

The partnership between the two associations builds on the progress made at the Forum des sciences de la vie held in Montreal on June 1^st.  Working together, BIOQuébec and Rx&D will help strengthen Quebec's position as a leader in developing and delivering new health care solutions.

"BIOQuébec and Rx&D share the same objective to ensure the vitality of the Quebec life sciences industry and the growth of its businesses, corporations and organizations. The partnership agreement between the two organizations reaffirms this commitment and reflects the shared determination to contribute to the development of this sector, considered a jewel of the Quebec economy" according to Mario Lebrun, BIOQuebec's Director General.

"What excites me the most about this partnership is that it is an excellent example of how collaboration can further enhance Quebec's research capacity and contribute to the growth of the knowledge economy of the province," said Russell Williams, President of Rx&D. "Formalizing the relationship between BIOQuébec and Rx&D is an important signal of progress in this new era of pharmaceutical and biopharmaceutical research," added Mr. Williams.

About BIOQuébec
BIOQuébec is a biotechnology and life science industry association representing nearly 100 member companies and R&D centers in Quebec. The association works to create a positive influence on the growth of the life science industry, including capital access, public policy, workforce development and international promotion.

About Rx&D
Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

Rx&D
Christine Choury
Media Relations
Telephone: [phone]
E-mail: [email protected]

BIOQuébec
Mario Lebrun
General Manager
Telephone: [phone]
E-mail: [email protected]m